- Home
- ASRT vs IAF Comparison
ASRT vs IAF Comparison
Compare ASRT & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- IAF
- Stock Information
- Founded
- ASRT 1995
- IAF 1985
- Country
- ASRT United States
- IAF United States
- Employees
- ASRT N/A
- IAF N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- IAF Finance/Investors Services
- Sector
- ASRT Health Care
- IAF Finance
- Exchange
- ASRT Nasdaq
- IAF Nasdaq
- Market Cap
- ASRT 88.4M
- IAF 115.5M
- IPO Year
- ASRT 1997
- IAF N/A
- Fundamental
- Price
- ASRT $0.89
- IAF $4.18
- Analyst Decision
- ASRT Strong Buy
- IAF
- Analyst Count
- ASRT 4
- IAF 0
- Target Price
- ASRT $3.19
- IAF N/A
- AVG Volume (30 Days)
- ASRT 912.6K
- IAF 90.4K
- Earning Date
- ASRT 11-11-2024
- IAF 01-01-0001
- Dividend Yield
- ASRT N/A
- IAF 11.44%
- EPS Growth
- ASRT N/A
- IAF N/A
- EPS
- ASRT N/A
- IAF N/A
- Revenue
- ASRT $125,763,000.00
- IAF N/A
- Revenue This Year
- ASRT N/A
- IAF N/A
- Revenue Next Year
- ASRT $1.84
- IAF N/A
- P/E Ratio
- ASRT N/A
- IAF N/A
- Revenue Growth
- ASRT N/A
- IAF N/A
- 52 Week Low
- ASRT $0.73
- IAF $3.60
- 52 Week High
- ASRT $1.80
- IAF $4.59
- Technical
- Relative Strength Index (RSI)
- ASRT 42.24
- IAF 27.16
- Support Level
- ASRT $0.90
- IAF $4.30
- Resistance Level
- ASRT $1.04
- IAF $4.39
- Average True Range (ATR)
- ASRT 0.07
- IAF 0.07
- MACD
- ASRT -0.01
- IAF -0.03
- Stochastic Oscillator
- ASRT 28.11
- IAF 24.51
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.